XML 35 R22.htm IDEA: XBRL DOCUMENT v3.24.3
Earnings per Share/Capital Stock (Tables)
 9 Months Ended
Sep. 30, 2024
Earnings Per Share [Abstract]  
Schedule of reconciliation of Registrant's net income and weighted average Common Shares outstanding for calculating basic net income per share
The following is a reconciliation of Registrant’s net income and weighted average Common Shares outstanding used to calculate basic EPS:
Basic: For The Three Months Ended 
 September 30,		 For The Nine Months Ended 
 September 30,
(in thousands, except per share amounts)2024202320242023
Net income$35,834 $31,565 $90,833 $104,493 
Less: impact from participating securities128 91 294 286 
Total income available to common shareholders$35,706 $31,474 $90,539 $104,207 
Weighted average Common Shares outstanding, basic37,564 36,977 37,302 36,974 
Basic earnings per Common Share$0.95 $0.85 $2.43 $2.82 
Schedule of reconciliation of Registrant's net income and weighted average Common Shares outstanding for calculating diluted net income per share
The following is a reconciliation of Registrant’s net income and weighted average Common Shares outstanding used to calculate diluted EPS:
Diluted: For The Three Months Ended 
 September 30,		 For The Nine Months Ended 
 September 30,
(in thousands, except per share amounts)2024202320242023
Common shareholders earnings, basic$35,706 $31,474 $90,539 $104,207 
Undistributed earnings for dilutive stock options and restricted stock units66 45 134 162 
Total common shareholders earnings, diluted$35,772 $31,519 $90,673 $104,369 
Weighted average Common Shares outstanding, basic37,564 36,977 37,302 36,974 
Stock-based compensation (1)
119 94 107 90 
Weighted average Common Shares outstanding, diluted37,683 37,071 37,409 37,064 
Diluted earnings per Common Share$0.95 $0.85 $2.42 $2.82 
(1)     In applying the treasury stock method of reflecting the dilutive effect of outstanding stock-based compensation in calculating diluted EPS, 135,575 and 106,879 restricted stock units, including performance awards to officers of the Company at September 30, 2024 and 2023, respectively, were deemed to be outstanding and included in the calculation of diluted EPS.